乳腺癌史
寿险:
- 标准
- 加费
- 除外(通常不出现)
- 延期
- 拒保
重疾:
- 标准(通常不出现)
- 加费(通常不出现)
- 除外
- 延期(通常不出现)
- 拒保
选择性雌激素受体调节剂
激素受体阳性乳腺癌术后常连续服用多年,以降低复发风险;也用于高危人群预防。
仍在服用不代表还在「治疗期」——多数公司把辅助内分泌治疗与化疗放疗分开看,但会据此确认分期与治疗结束日期。
寿险:
重疾:
把病名、确诊日期、用药与剂量、最近检查结果带给持牌顾问,请他先做预审再正式投保。
各公司核保不同,以核保结果为准。本页是一般信息,不是个人医疗或投保建议;病与药的介绍只引官方来源。
先看导读,再看图;点图放大、左右翻页,每张卡都有可分享的详情页。卡上每个字都出自本站正文,不列费率。

价格是个人化的
保费按年龄、性别、是否吸烟和健康状况报价,本站不列费率。持牌保险顾问可在多家公司之间比较报价(可报价的公司以其签约为准),把条款差异列在同一页上。
询价前要准备什么 →Health and insurability atlas / By medication
Selective estrogen receptor modulator
Tamoxifen
Often taken for years after surgery for hormone-receptor-positive breast cancer to cut recurrence risk; also used for prevention in high-risk women.
Still taking it doesn't necessarily mean 'in treatment' — many insurers treat adjuvant hormone therapy differently from chemo or radiation, but use it to confirm stage and treatment dates.
Life:
Critical illness:
Bring the condition, diagnosis date, medications and doses, and recent test results to a licensed advisor and ask for a pre-assessment before a formal application.
Underwriting differs by insurer; the insurer’s decision is final. General information only, not personal medical or insurance advice; condition and medication descriptions cite official sources.